Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000898430-00-001062
Filing Date
2000-03-30
Accepted
2000-03-30 00:00:00
Documents
18
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE YEAR ENDED 12/31/99 10-K 254636
2 AMENDED AND RESTATED 1990 STOCK OPTION PLAN EX-10.3 20708
3 1997 STOCK OPTION PLAN EX-10.19 20223
4 VOTING AGREEMENT DATED 12/17/97 EX-10.52 12674
5 REGISTRATION RIGHTS AGREEMENT DATED 12/17/97 EX-10.53 34556
6 NON INCENTIVE STOCK OPTION AGMT DATED 11/09/99 EX-10.54 13026
7 NON INCENTIVE STOCK OPTION AGMT DATED 11/09/99 EX-10.55 13039
8 NON INCENTIVE STOCK OPTION AGMT DATED 11/09/99 EX-10.56 12756
9 NON INCENTIVE STOCK OPTION AGMT DATED 11/09/99 EX-10.57 12261
10 NON INCENTIVE STOCK OPTION AGMT DATED 11/09/99 EX-10.58 12755
11 STOCK OPTION AGMT DATED 3/12/96 EX-10.59 9485
12 AMENDMENT DATED 5/25/99 EX-10.60 2135
13 AMENDMENT DATED 5/25/99 EX-10.61 2111
14 FORM OF INDEMNIFICATION AGREEMENT EX-10.62 23771
15 AMENDMENT DATED 11/30/99 EX-10.63 18012
16 LIST OF SUBSIDIARIES EX-21 675
17 CONSENT OF KPMG LLP EX-23.(A) 977
18 FINANCIAL DATA SCHEDULE EX-27 2860
  Complete submission text file 0000898430-00-001062.txt   470072
Mailing Address 9 PARKER IRVINE CA 92618
Business Address 9 PARKER IRVINE CA 92618 9494709011
NEXELL THERAPEUTICS INC (Filer) CIK: 0000864009 (see all company filings)

EIN.: 061192468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19153 | Film No.: 587252
SIC: 2834 Pharmaceutical Preparations